10. Juni 2023 | Legal
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
(digitaljournal.com, USA, 09.06.2023)
...